Clinical Trial Update: Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy and safety of ALV003 in symptomatic celiac disease patients, status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• ALV003

Snippet

Sponsor: Alvine Pharmaceuticals Inc. | Conditions: Celiac Disease | Phase 2 | Status: UNKNOWN